| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jan 03, 2025 | Jan 07, 2025 | Lebwohl David EVP Chief Medical Officer | Sell | Intellia Therapeutics, Inc. | NTLA | $12.18 | $116,404 | -9.83% |
| Jan 03, 2024 | Jan 05, 2024 | Lebwohl David EVP Chief Medical Officer | Sell | Intellia Therapeutics, Inc. | NTLA | $29.46 | $172,135 | -9.70% |
| Jan 04, 2023 | Jan 06, 2023 | Lebwohl David EVP Chief Medical Officer | Sell | Intellia Therapeutics, Inc. | NTLA | $37.21 | $95,779 | -9.11% |
| Jan 01, 2022 | Mar 04, 2022 | Lebwohl David EVP Chief Medical Officer | Sell | Intellia Therapeutics, Inc. | NTLA | $112.24 | $117,964 | -4.08% |
| Nov 05, 2021 | Nov 09, 2021 | Lebwohl David EVP Chief Medical Officer | Sell | Intellia Therapeutics, Inc. | NTLA | $132.72 | $318,535 | -21.59% |
| Oct 14, 2021 | Oct 15, 2021 | Lebwohl David EVP Chief Medical Officer | Sell | Intellia Therapeutics, Inc. | NTLA | $128.44 | $308,249 | -21.59% |
| Sep 21, 2021 | Sep 23, 2021 | Lebwohl David EVP Chief Medical Officer | Sell | Intellia Therapeutics, Inc. | NTLA | $149.81 | $359,544 | -75.21% |
| Aug 30, 2021 | Sep 01, 2021 | Lebwohl David EVP Chief Medical Officer | Sell | Intellia Therapeutics, Inc. | NTLA | $158.04 | $379,300 | -75.21% |
| Aug 09, 2021 | Aug 11, 2021 | Lebwohl David EVP Chief Medical Officer | Sell | Intellia Therapeutics, Inc. | NTLA | $164.05 | $393,720 | -75.21% |